Ella R, Reddy S, Blackwelder W, Potdar V, et al. Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial. Lancet 2021 Nov 11. pii: S0140-6736(21)02000.
PMID: 34774196